Vale SA
VALE
D.R. Horton
DHI
Taylor Morrison Home
TMHC
Petroleo Brasileiro SA Petrobras
PBR
Ecopetrol
EC
US Stock MarketDetailed Quotes
AUTL Autolus Therapeutics
- 1.790
- -0.030-1.65%
Close Mar 18 16:00 ET
- 1.850
- +0.060+3.35%
Post 20:01 ET
476.36MMarket Cap-1.47P/E (TTM)
1.850High1.740Low557.29KVolume1.800Open1.820Pre Close998.51KTurnover0.41%Turnover RatioLossP/E (Static)266.12MShares6.60052wk High1.00P/B246.02MFloat Cap1.68052wk Low--Dividend TTM137.44MShs Float53.240Historical High--Div YieldTTM6.04%Amplitude1.600Historical Low1.791Avg Price1Lot Size
About Autolus Therapeutics Company
Autolus Therapeutics Plc is a biopharmaceutical company, which engages in the development and commercialization of gene therapies. It uses proprietary and modular T cell programming technologies that are designed to recognize cancer cells, break down their defense mechanisms, and attack and kill these cells. The company was founded by Martin Pule in September 2014 and is headquartered in London, the United Kingdom.
Company Profile
SymbolAUTL
Company NameAutolus Therapeutics
Listing DateJun 22, 2018
Issue Price17.00
Founded2018
CEODr. Christian Itin, PhD.
MarketNASDAQ
Employees471
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressThe Mediaworks,191 Wood Lane,White City
CityLondon
ProvinceGreater London
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeW12 7FP
Phone44-20-3829-6230
Websitehttp://www.autolus.com
Company Executives
- Name
- Position
- Salary
- Dr. Christian Itin, PhD.
- Chief Executive Officer and Director
- 1.92M
- Robert F. Dolski
- Senior Vice President, Chief Financial Officer
- --
- Dr. Edgar Braendle
- Senior Vice President and Chief Development Officer
- --
- Brent Rice
- Senior Vice President and Chief Commercial Officer
- --
- David Brochu
- Senior Vice President and Chief Technical Officer
- --
- Christopher Vann
- Senior Vice President and Chief Operating Officer
- --
- Martin Pule
- Senior Vice President and Chief Scientific Officer
- --
- Dr. Christopher Willia PhD
- Senior Vice President and Chief Business Development Officer
- --
- Alexander Swan
- Senior Vice President, Chief Human Resources Officer
- --
- Michael W. Bonney
- Chairman of the Board
- --
- Dr. Elisabeth Leiderman, M.D.
- Director
- 12.73K
- Dr. Ravi Madduri Rao
- Director
- --
- Robert W. Azelby
- Director
- --
- Dr. Martin Murphy, PhD
- Independent Director
- 158.28K
- William D. Young
- Independent Director
- 175.82K
- John E. Berriman
- Independent Director
- 163.15K
- Cynthia M. Butitta
- Independent Director
- 164.65K
- Linda C. Bain
- Independent Director
- 169.52K
- Dr. Joseph Anderson, PhD.
- Independent Director
- 195.65K
- Dr. Robert Iannone, M.D.
- Independent Director
- 134.86K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.